These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 31293151)

  • 21. Novel PLS3 variants in X-linked osteoporosis: Exploring bone material properties.
    Balasubramanian M; Fratzl-Zelman N; O'Sullivan R; Bull M; Fa Peel N; Pollitt RC; Jones R; Milne E; Smith K; Roschger P; Klaushofer K; Bishop NJ
    Am J Med Genet A; 2018 Jul; 176(7):1578-1586. PubMed ID: 29736964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Calcium-Dependent Switch Helix of L-Plastin Regulates Actin Bundling.
    Ishida H; Jensen KV; Woodman AG; Hyndman ME; Vogel HJ
    Sci Rep; 2017 Feb; 7():40662. PubMed ID: 28145401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.
    Janzen E; Mendoza-Ferreira N; Hosseinibarkooie S; Schneider S; Hupperich K; Tschanz T; Grysko V; Riessland M; Hammerschmidt M; Rigo F; Bennett CF; Kye MJ; Torres-Benito L; Wirth B
    Brain; 2018 Aug; 141(8):2343-2361. PubMed ID: 29961886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mice lacking plastin-3 display a specific defect of cortical bone acquisition.
    Yorgan TA; Sari H; Rolvien T; Windhorst S; Failla AV; Kornak U; Oheim R; Amling M; Schinke T
    Bone; 2020 Jan; 130():115062. PubMed ID: 31678489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Expression of PLS3 Correlates with Better Outcome in Sézary Syndrome.
    Boonk SE; Zoutman WH; Putter H; Ram-Wolff C; Felcht M; Klemke CD; Ranki A; Quaglino P; Whittaker S; Bagot M; Willemze R; Vermeer MH
    J Invest Dermatol; 2017 Mar; 137(3):754-757. PubMed ID: 27984038
    [No Abstract]   [Full Text] [Related]  

  • 26. Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics.
    Fahiminiya S; Majewski J; Al-Jallad H; Moffatt P; Mort J; Glorieux FH; Roschger P; Klaushofer K; Rauch F
    J Bone Miner Res; 2014 Aug; 29(8):1805-14. PubMed ID: 24616189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel nonsense variant in PLS3 causes X-linked osteoporosis in a Chinese family.
    Wang L; Bian X; Cheng G; Zhao P; Xiang X; Tian W; Li T; Zhai Q
    Ann Hum Genet; 2020 Jan; 84(1):92-96. PubMed ID: 31347706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
    Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
    Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FSCN1 Promotes Epithelial-Mesenchymal Transition Through Increasing Snail1 in Ovarian Cancer Cells.
    Li J; Zhang S; Pei M; Wu L; Liu Y; Li H; Lu J; Li X
    Cell Physiol Biochem; 2018; 49(5):1766-1777. PubMed ID: 30231243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
    Wesseling-Perry K; Mäkitie RE; Välimäki VV; Laine T; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2340-2348. PubMed ID: 28379384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PLS3 Mutations in X-Linked Osteoporosis: Clinical and Bone Characteristics of Two Novel Mutations.
    Kannu P; Mahjoub A; Babul-Hirji R; Carter MT; Harrington J
    Horm Res Paediatr; 2017; 88(3-4):298-304. PubMed ID: 28605746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plastin3 is associated with epithelial-mesenchymal transition and poor prognosis in gastric cancer.
    Kurashige J; Yokobori T; Mima K; Sawada G; Takahashi Y; Ueo H; Takano Y; Matsumura T; Uchi R; Eguchi H; Sudo T; Sugimachi K; Mori M; Baba H; Mimori K
    Oncol Lett; 2019 Feb; 17(2):2393-2399. PubMed ID: 30675305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the PLS3 Gene in Circulating Cells in Patients with Colorectal Cancer.
    Kujawski R; Przybyłowska-Sygut K; Mik M; Lewandowski M; Trzciński R; Berut M; Dziki Ł; Majsterek I; Dziki A
    Pol Przegl Chir; 2015 Feb; 87(2):59-64. PubMed ID: 26146096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma plastin-3: A tumor marker in patients with non-small-cell lung cancer treated with nivolumab.
    Kuriyama K; Yokobori T; Sohda M; Nakazawa N; Yajima T; Naruse I; Kuwano H; Shirabe K; Kaira K; Saeki H
    Oncol Lett; 2021 Jan; 21(1):11. PubMed ID: 33240417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of L-plastin in nasal polyp of patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease.
    Takabayashi T; Tanaka Y; Susuki D; Yoshida K; Tomita K; Sakashita M; Imoto Y; Kato Y; Narita N; Nakayama T; Haruna S; Schleimer RP; Fujieda S
    Allergy; 2019 Jul; 74(7):1307-1316. PubMed ID: 30479022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the EF-Hand Calcium-Binding Domains of Human Plastins.
    Khassan O; Jensen KV; Woodman AG; Vogel HJ; Ishida H
    Methods Mol Biol; 2019; 1929():245-260. PubMed ID: 30710278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-plastin Ser5 phosphorylation in breast cancer cells and in vitro is mediated by RSK downstream of the ERK/MAPK pathway.
    Lommel MJ; Trairatphisan P; Gäbler K; Laurini C; Muller A; Kaoma T; Vallar L; Sauter T; Schaffner-Reckinger E
    FASEB J; 2016 Mar; 30(3):1218-33. PubMed ID: 26631483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different Ca²⁺-sensitivities between the EF-hands of T- and L-plastins.
    Miyakawa T; Shinomiya H; Yumoto F; Miyauchi Y; Tanaka H; Ojima T; Kato YS; Tanokura M
    Biochem Biophys Res Commun; 2012 Dec; 429(3-4):137-41. PubMed ID: 23142595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1.
    Yu W; Li D; Zhang Y; Li C; Zhang C; Wang L
    Technol Cancer Res Treat; 2019; 18():1533033819892264. PubMed ID: 31789129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice.
    Strathmann EA; Peters M; Hosseinibarkooie S; Rigo FW; Bennett CF; Zaworski PG; Chen KS; Nothnagel M; Wirth B
    PLoS One; 2018; 13(9):e0203398. PubMed ID: 30188931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.